Jatenzo for Low Testosterone
This trial will compare patient satisfaction with Jatenzo, an oral testosterone medication, to other forms of testosterone therapy.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there still opportunities for enrolment in this clinical investigation?
"This scientific trial is no longer accepting new volunteers. The experiment was first advertised on June 18th 2021 and the latest update occurred November 7th 2022. If you are still looking for a clinical trial, there are presently 6 studies recruiting people with testosterone deficiency and 8 trials welcoming participants who use Jatenzo medication."
What kind of qualifications must participants meet to be eligible for this research?
"This research is enrolling 40 volunteers aged 18 to 65 that display testosterone deficiency. In order for one's application to be valid, they must provide written consent prior to any procedures and comply with the regulations passed by an Institutional Review Board (IRB). Additionally, only males are eligible for this study."
Is the age range for this clinical trial limited to those over 25 years old?
"The age requirements for this trial are clearly outlined in the enrollment criteria: patients must be of legal consent and not exceed 65 years old."
What is the aim of this experiment?
"The primary endpoint of this research, that will be assessed between Baseline and 3 months as well as Baseline and 6 months, is the transformation in patient satisfaction determined by TSQM-9. Secondary endpoints include alteration in Estrogen levels (pg/mL) measured via venous puncture blood draw; change in Prostate Specific Antigen (PSA) levels (ng/dL), also obtained through venipuncture; and transformations in Testosterone concentrations (ng/dL)."
Has the governmental body given Jatenzo its seal of approval?
"As it is a Phase 4 trial, Jatenzo has already been approved and thus was given an appropriate safety score of 3."
Can you elaborate on any prior research regarding Jatenzo?
"Currently, 8 clinical trials are underway for Jatenzo. As of now, none have progressed to Phase 3 yet. Although the primary testing site is located in Boston, Massachusetts, 46 different locations are running studies related to this medication."
What is the size of the sample population currently participating in this trial?
"Currently, this clinical trial is not recruiting participants. This study was first listed on June 18th 2021 and the last update occurred November 7th 2022. For those exploring other medical studies, there are 6 trials looking to recruit people with testosterone deficiency and 8 trials actively enrolling for Jatenzo therapy."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Miami: < 24 hours
Average response time
- < 2 Days